Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries

作者：Xuetong Tao, Tong Li, Ziba Gandomkar, Patrick Brennan, Warren Reed · 发表于：Asia-Pacific Journal of Clinical Oncology · 年份：2023 · DOI：10.1111/ajco.13958 · 被引用次数：97 · 研究领域：Global Cancer Incidence and Screening、Cancer Risks and Factors、Breast Cancer Treatment Studies

Breast cancer was the most diagnosed malignant neoplasm and the second leading cause of cancer mortality among Chinese females in 2020. Increased risk factors and widespread adoption of westernized lifestyles have resulted in an upward trend in the occurrence of breast cancer. Up to date knowledge on the incidence, mortality, survival, and burden of breast cancer is essential for optimized cancer prevention and control. To better understand the status of breast cancer in China, this narrative literature review collected data from multiple sources, including studies obtained from the PubMed database and text references, national annual cancer report, government cancer database, Global Cancer Statistics 2020, and Global Burden of Disease study (2019). This review provides an overview of the incidence, mortality, and survival rates of breast cancer, as well as a summary of disability-adjusted life years associated with breast cancer in China from 1990 to 2019, with comparisons to Japan, South Korea, Australia and the United States.